Shp-2 is critical for ERK and metabolic engagement downstream of IL-15 receptor in NK cells.
Charlène NiogretS M Shahjahan MiahGiorgia RotaNicolas P FontaHaiping WangWerner HeldWalter BirchmeierVeronica SexlWentian YangÉric VivierPing-Chih HoLaurent BrossayGreta GuardaPublished in: Nature communications (2019)
The phosphatase Shp-2 was implicated in NK cell development and functions due to its interaction with NK inhibitory receptors, but its exact role in NK cells is still unclear. Here we show, using mice conditionally deficient for Shp-2 in the NK lineage, that NK cell development and responsiveness are largely unaffected. Instead, we find that Shp-2 serves mainly to enforce NK cell responses to activation by IL-15 and IL-2. Shp-2-deficient NK cells have reduced proliferation and survival when treated with high dose IL-15 or IL-2. Mechanistically, Shp-2 deficiency hampers acute IL-15 stimulation-induced raise in glycolytic and respiration rates, and causes a dramatic defect in ERK activation. Moreover, inhibition of the ERK and mTOR cascades largely phenocopies the defect observed in the absence of Shp-2. Together, our data reveal a critical function of Shp-2 as a molecular nexus bridging acute IL-15 signaling with downstream metabolic burst and NK cell expansion.
Keyphrases
- nk cells
- signaling pathway
- high dose
- cell proliferation
- low dose
- intensive care unit
- type diabetes
- machine learning
- metabolic syndrome
- respiratory failure
- single cell
- social media
- adipose tissue
- molecular dynamics
- endothelial cells
- density functional theory
- acute respiratory distress syndrome
- soft tissue
- free survival